Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan)(AC) response and resistance
S Cleator, A Tsimelzon, A Ashworth, M Dowsett… - Breast cancer research …, 2006 - Springer
Summary Introduction Doxorubicin and cyclophosphamide (Adriamycin/cytoxan, AC) is a
standard chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
standard chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan)(AC) response and resistance
S Cleator, A Tsimelzon, A Ashworth… - Breast cancer …, 2006 - pubmed.ncbi.nlm.nih.gov
Introduction Doxorubicin and cyclophosphamide (Adriamycin/cytoxan, AC) is a standard
chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan)(AC) response and resistance
S Cleator, A Tsimelzon, A Ashworth, M Dowsett… - Breast Cancer Research …, 2006 - infona.pl
Summary Introduction Doxorubicin and cyclophosphamide (Adriamycin/cytoxan, AC) is a
standard chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
standard chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan)(AC) response and resistance
S Cleator, A Tsimelzon, A Ashworth… - Breast Cancer …, 2006 - search.proquest.com
Abstract Introduction Doxorubicin and cyclophosphamide (Adriamycin/cytoxan, AC) is a
standard chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
standard chemotherapy regimen for breast cancer, but de novo resistance is frequent. We …
[引用][C] Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan)(AC) response and resistance
S CLEATOR, A TSIMELZON… - Breast cancer …, 2006 - pascal-francis.inist.fr
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC)
response and resistance CNRS Inist Pascal-Francis CNRS Pascal and Francis …
response and resistance CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan)(AC) response and resistance.
S Cleator, A Tsimelzon, A Ashworth… - … Cancer Research and …, 2006 - europepmc.org
Doxorubicin and cyclophosphamide (Adriamycin/cytoxan, AC) is a standard chemotherapy
regimen for breast cancer, but de novo resistance is frequent. We hypothesized that gene …
regimen for breast cancer, but de novo resistance is frequent. We hypothesized that gene …